Penggunaan Metilprednisolon Sebagai Terapi Sindrom Nefrotik dengan Efusi Pleura pada Anak 16 tahun

Samia Wildana A; Nurifah Nurifah; Sri Hastuti Andayani

doi:10.55606/jurrike.v5i1.8180

Authors

Samia Wildana A Universitas YARSI
Nurifah Nurifah RS Bhayangkara TK I Pusdokkes Polri
Sri Hastuti Andayani Universitas YARSI

DOI:

https://doi.org/10.55606/jurrike.v5i1.8180

Keywords:

Edema, Hypoalbuminemia, Methylprednisolone, Nephrotic Syndrome, Proteinuria

Abstract

Nephrotic syndrome (NS) is a kidney disorder characterized by massive proteinuria, hypoalbuminemia, edema, and hypercholesterolemia, most commonly occurring in children. This disease can be caused by various conditions, such as minimal change disease, FSGS, or lupus nephritis. This case report discusses a 16-year-old boy who experienced nephrotic syndrome with symptoms of swelling throughout his body, accompanied by decreased appetite and a productive cough. The patient presented with complaints of swelling throughout his body that began 7 days after hospitalization and was accompanied by coughing and shortness of breath. A physical examination revealed massive edema, abdominal hypertympany, and shifting dullness. Laboratory tests revealed proteinuria, hypoalbuminemia, and decreased serum albumin. Other supporting tests confirmed nephrotic syndrome. The patient received medication therapy including diuretics, corticosteroids in the form of methylprednisolone, and albumin. Nephrotic syndrome in children can develop gradually and requires management that includes steroids, diuretics, and close monitoring of kidney function and electrolytes. Early detection and appropriate treatment can help improve the patient's prognosis.

Downloads

Download data is not yet available.

References

Australian Government Department of Health and Aged Care. (2025). Prednisolone-equivalent dosing, duration of action and anti-inflammatory activity for various systemic corticosteroid preparations [Table]. The Australian Immunisation Handbook. https://immunisationhandbook.health.gov.au/resources/tables/table-prednisolone-equivalent-dosing-duration-of-action-and-anti-inflammatory-activity-for-various-systemic-corticosteroid-preparations

Bockenhauer, D., et al. (2020). Epidemiology of nephrotic syndrome. Kidney International, 98(4), 935–944.

Eddy, A. A., & Symons, J. M. (2003). Nephrotic syndrome in childhood. The Lancet, 362(9384), 629–639. https://doi.org/10.1016/S0140-6736(03)14184-0

Fakhoury, M., et al. (2022). Childhood nephrotic syndrome: Causes, mechanisms, and management. Pediatric Nephrology, 37(4), 853–863.

Gipson, D. S., Massengill, S. F., Yao, L., Nagaraj, S., Smoyer, W. E., Mahan, J. D., Wigfall, D., Miles, P., Powell, L., Lin, J. J., Trachtman, H., Greenbaum, L. A., & Radeva, M. K. (2009). Management of childhood onset nephrotic syndrome. Pediatrics, 124(2), 747–757. https://doi.org/10.1542/peds.2008-1559

Hogan, J., Radhakrishnan, J., & Appel, G. B. (2020). Treatment of idiopathic focal segmental glomerulosclerosis in children. Clinical Journal of the American Society of Nephrology, 15(5), 723–734. https://doi.org/10.2215/CJN.11530919

Husain, S., et al. (2022). Diagnosis and management of nephrotic syndrome in children. Indian Journal of Pediatrics, 89(1), 63–72.

Ikatan Dokter Anak Indonesia. (2018). Buku ajar respirologi anak (Edisi ke-2, Bab pneumonia atipik, hlm. 260–265). Badan Penerbit IDAI.

Kidney Disease: Improving Global Outcomes (KDIGO) Nephrotic Syndrome in Children Work Group. (2025). KDIGO 2025 clinical practice guideline for the management of nephrotic syndrome in children. Kidney International, 107(Suppl 5S), S241–S289. https://doi.org/10.1016/j.kint.2024.11.007

Kliegman, R. M., St. Geme, J. W., Blum, N. J., Shah, S. S., Tasker, R. C., & Wilson, K. M. (2020). Nelson textbook of pediatrics (21st ed.). Elsevier.

Kumar, A., Narayan, M., & Kumari, S. (2024). Clinicopathological pattern of renal biopsies in children with nephrotic syndrome. Clinical Medicine Research, 22(2), 76–83. https://doi.org/10.3121/cmr.2024.1917

Liu, M., & Cai, Y. (2025). Efficacy and safety of methylprednisolone pulse therapy and conventional oral prednisone for pediatric patients with nephrotic syndrome. Alternative Therapies in Health and Medicine, 31(1), 430–435.

Liu, Y., et al. (2021). Steroid-resistant nephrotic syndrome in children. Pediatric Nephrology, 36(9), 2155–2164.

Ruggenenti, P., et al. (2021). The role of immunosuppressive therapy in nephrotic syndrome. Nephrology Dialysis Transplantation, 36(2), 300–307.

Salahudeen, A. K., & Radhakrishnan, J. (2020). Focal segmental glomerulosclerosis in children: Pathogenesis and management. Journal of Clinical Nephrology, 43(3), 276–285.

Singla, N., Jain, N., & Bhatnagar, A. (2020). Current status of treatment of latent tuberculosis infection in India. Indian Journal of Medical Specialities, 11(2), 57–63. https://ijmsweb.com/current-status-of-treatment-of-latent-tuberculosis-infection-in-india/

Trautmann, A., Boyer, O., Hodson, E. M., et al. (2023). IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatric Nephrology, 38(4), 877–919.

Trihono, P. P., Alatas, H., Tambunan, T., & Pardede, S. O. (2012). Konsensus tata laksana sindrom nefrotik idiopatik pada anak (Edisi kedua, cetakan kedua). Unit Kerja Koordinasi Nefrologi Ikatan Dokter Anak Indonesia.

Uwaezuoke, S. N. (2015). Steroid-sensitive nephrotic syndrome in children: Triggers of relapse and evolving hypotheses on pathogenesis. Italian Journal of Pediatrics, 41, 19. https://doi.org/10.1186/s13052-015-0123-9

World Health Organization. (2022). Latent tuberculosis infection: Updated and consolidated guidelines for programmatic management (2nd ed.). World Health Organization. https://www.who.int/publications/i/item/9789240052540

Zahedi, F., et al. (2021). Minimal change disease in children: Clinical course and response to steroid therapy. Pediatrics & Neonatology, 62(6), 651–657.